BGI Platinum Research Partner Programme - BGI continually seeks to establish and foster collaborative scientific studies, alliances and partnerships internationally to uncover the unknowns of the life sciences to benefit the world. Guided by the vision of “Omics for all”, BGI Research’s mission is to conduct scientific research in life sciences including genomics, epigenetics, transcriptomics, metagenomics, proteomics, metabolomics, immunology, and other enabling technologies such as biomedical imaging, biometrics, artificial intelligence and wearable devices. In combination, these technologies can be used to contribute to human health, disease control and prevention throughout the entire life cycle and can be applied to conservation of environments and ecosystems. BGI Research is actively looking for enthusiastic research partners that share the same vision to join in the perpetual quest for better health and better life for the world. To achieve that we believe the key is collaboration and innovation, e.g. collaborate with Australian universities and research institutions. By becoming a BGI Platinum Research Partner you can enjoy the following benefits:
BGI Australia Research Collaborations Since the inception in April 2016, BGI Australia have established extensive collaborations with universities and research institutes all over Australia.
In Aug. 2016 BGI Agriculture Group signed a memorandum with Commonwealth Scientific and Industrial Research Organisation through its Agriculture and Food Business Unit in respect of millet breeding, production and genetic improvement.
In Aug. 2016 BGI Australia signed a memorandum with Griffith University with regards to a number of projects involving genomics, gene sequencing, genetic diagnostic and screening, phonemics and other -omics studies.
BGI and QIMR Berghofer Medical Research Institute signed a memorandum regarding collaborations on a genomics-based research and education programme focused on precision medicine.
BGI Australia and the University of Melbourne signed a Memorandum of Understanding to engage in scientific collaborations in the area of One Health using ‘omic and informatic technologies, with the aim to build a comprehensive, world-class program and joint-centre in infectious diseases.
BGI and Centre for Advanced Imaging University of Queensland formed a partnership to investigate the feasibility of integrating anatomical ultra-high field MRI and genomics sequencing data, with the aim of developing early diagnostic tools across a broad range of clinically significant disorders.
BGI Inks MoU with the the Queensland Alliance for Agriculture and Food Innovation (QAAFI), University of Queensland to strengthen the to strengthen the extensive collaboration to establish Australia's very own gene bank and other key projects, and joint exchange education programmes of research staff and high degree student.
BGI is collaborating with the University of Queensland on a biodiversity project "Managing Regime Shifts and Fisheries Collapse on the Great Barrier Reef". The objectives are to quantify the magnitude and frequency of coral to macro-algal regime shifts on the GBR over the past 2000 years, reconstruct past occurrences of exploited fisheries.
BGI and James Cook University's collaborative project "Depth Adaptation and Scope for Vertical Connectivity" aims at assessing the mechanisms of depth adaptation and the strength of connectivity of keystone coral species across a depth gradient on tropical coral reefs of French Polynesia - a remote and highly understudied area of the world.
BGI is the Next-Gen Sequencing partner of the “Artificial Intelligence and Genomics to Predict Cancer Treatment” project, awarded a $2.6 million CRC-P Grant (Cooperative Research Centre Projects) by the Australian Government. Other partners include Max Kelsen, QIMR Berghofer, QLD Health Metro North Hospital, and genomiQa.
BGI and Maxwell Plus have executed a collaborative research project “A model to predict risk of developing advanced or metastatic prostate cancer using genetic makeup and family history of cancers” in Sep. 2018. All samples will be sequenced on the cutting-edge BGI genetic sequencer MGISEQ-2000 in the BGI Australia laboratory
BGI and Xing Technologies signed a MOU in Aug 2018 supporting collaborative research and product innovation in DNB technology, optimising current DNA nanoball technology to improve sequencing data quality and throughput resulting in reduced sequencing costs; and point-of-care product.